Clinical Trials · NCT06951776
Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Peking University Third Hospital
- Enrollment
- 28
- Start date
- May 2025
- Locations
- See registry
- Primary endpoint
- Change of CTX from baseline after administration